Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 11/2014

01-11-2014 | Short Communication

Coexisting primary Sjögren’s syndrome and sarcoidosis: coincidence, mutually exclusive conditions or syndrome?

Authors: T. Santiago, M. Santiago, J. Rovisco, J. Ferreira, C. Duarte, A. Malcata, J. A. P. Da Silva

Published in: Rheumatology International | Issue 11/2014

Login to get access

Abstract

Herein, we describe a 44-year-old female diagnosed with histologically proven coexistence of primary Sjögren’s syndrome and sarcoidosis with pulmonary and muscular involvement. The differential diagnosis may be difficult, but this is not an exceptional case, which highlights the need to critically revise the consideration of sarcoidosis as an exclusion for primary Sjögren’s syndrome, as established in current classification criteria.
Literature
1.
Hoes JN, Jacobs JW, Boers M et al (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66(12):1560–1567PubMedCrossRefPubMedCentral
2.
Shiboski SC, Shiboski CH, Criswell L et al (2012) American college of rheumatology classification criteria for Sjogren’s syndrome: a data-driven, expert consensus approach in the Sjogren’s international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken) 64(4):475–487CrossRef
3.
Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558PubMedCrossRefPubMedCentral
4.
Mansour MJ, Al-Hashimi I, Wright JM (2007) Coexistence of Sjogren’s syndrome and sarcoidosis: a report of five cases. J Oral Pathol Med 36(6):337–341PubMedCrossRef
5.
Gal I, Kovacs J, Zeher M (2000) Case series: coexistence of Sjogren’s syndrome and sarcoidosis. J Rheumatol 27(10):2507–2510PubMed
6.
Ramos-Casals M, Brito-Zeron P, Garcia-Carrasco M, Font J (2004) Sarcoidosis or Sjogren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 83(2):85–95CrossRef
7.
8.
Hansen SR, Hetta AK, Omdal R (2008) Primary Sjogren’s syndrome and sarcoidosis: coexistence more than by chance? Scand J Rheumatol, pp 485–486
9.
van de Loosdrecht A, Kalk W, Bootsma H, Henselmans JM, Kraan J, Kallenberg CG (2001) Simultaneous presentation of sarcoidosis and Sjogren’s syndrome. Rheumatology (Oxford) 40(1):113–115CrossRef
10.
Schutt AC, Bullington WM, Judson MA (2010) Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med 104(5):717–723PubMedCrossRef
11.
Takemura T, Hiraga Y, Oomichi M et al (1995) Ultrastructural features of alveolitis in sarcoidosis. Am J Respir Crit Care Med 152(1):360–366PubMedCrossRef
12.
Giotaki H, Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM (1986) Labial minor salivary gland biopsy: a highly discriminatory diagnostic method between sarcoidosis and Sjogren’s syndrome. Respiration 50(2):102–107PubMedCrossRef
13.
Marx RE, Hartman KS, Rethman KV (1988) A prospective study comparing incisional labial to incisional parotid biopsies in the detection and confirmation of sarcoidosis, Sjogren’s disease, sialosis and lymphoma. J Rheumatol 15(4):621–629PubMed
14.
Le Roux K, Streichenberger N, Vial C et al (2007) Granulomatous myositis: a clinical study of thirteen cases. Muscle Nerve 35(2):171–177PubMedCrossRef
15.
Fayad F, Liote F, Berenbaum F, Orcel P, Bardin T (2006) Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol 33(1):98–103PubMed
Metadata
Title
Coexisting primary Sjögren’s syndrome and sarcoidosis: coincidence, mutually exclusive conditions or syndrome?
Authors
T. Santiago
M. Santiago
J. Rovisco
J. Ferreira
C. Duarte
A. Malcata
J. A. P. Da Silva
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3024-0

Other articles of this Issue 11/2014

Rheumatology International 11/2014 Go to the issue

Review Article

Growth abnormalities in children and adolescents with juvenile idiopathic arthritis

Original Article

Low bone mineral density in young individuals is associated with greater gingival inflammation and recession

Short Communication

Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositis

Original Article

Establishing hospital admission criteria of pediatric Henoch–Schonlein purpura

Short Communication

Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up

Original Article

Increased dental visits in patients prior to diagnosis of primary Sjögren’s syndrome: a population-based study in Taiwan
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits